In a pivotal three-day strategic dialogue held in early March 2025, the Kingdom of Belgium and the World Health Organization (WHO) concluded a comprehensive review of their longstanding partnership. This high-level consultation, which brought together senior representatives from the Belgian Federal government, the Flemish government, and the Walloon government, served as a blueprint for aligning national development priorities with the WHO’s evolving global health agenda. As the world faces an increasingly complex landscape of biological risks, shifting geopolitical priorities, and the urgent need for universal health coverage (UHC), the dialogue underscored a renewed, multi-year commitment to multilateralism and sustainable health systems.
Main Facts: A Partnership Rooted in Strategic Alignment
The strategic dialogue, spanning from March 2–5, 2025, was designed to evaluate the efficacy of existing joint programs and recalibrate the Belgium-WHO cooperation framework. Led by H.E. Christophe Payot, Ambassador of Belgium to the United Nations and other international organizations in Geneva, the Belgian delegation engaged in intensive technical and political sessions with WHO leadership, including experts from the Organization’s headquarters and its Regional Offices for Africa and Europe.
The core objectives of the meeting were threefold:
- Universal Health Coverage (UHC): Strengthening the resilience of health systems to ensure that quality care is accessible to all, without financial hardship.
- Equitable Access: Accelerating the availability of vaccines, essential medicines, and life-saving health technologies, particularly in low- and middle-income countries.
- Crisis Preparedness: Bolstering the global architecture for health emergency prevention, specifically in the context of the ongoing negotiations for a global pandemic agreement and the adoption of the "One Health" approach.
This summit was not merely a retrospective review but a forward-looking exercise aimed at integrating Belgium’s development cooperation priorities into the WHO’s 14th General Programme of Work (GPW14).
Chronology of the Strategic Dialogue
The three-day engagement was structured to provide both a macro-level overview of global health governance and micro-level insights into country-specific implementation.
Day 1: Navigating the Global Health Landscape
The dialogue opened with a high-level exchange on the shifting global health paradigm. The parties reviewed the legacy of the 2024 Belgian Presidency of the Council of the European Union, which served as a catalyst for elevated discussions on health security. Belgian delegates were briefed by WHO technical experts on the internal navigation of the organization during current geopolitical and economic challenges. This session set the stage for understanding how Belgium’s multi-year funding cycles can best support the agility required in modern global health.
Day 2: Technical Deep-Dives and Field Implementation
The second day focused on the "Access to Medicines" program and health emergency response. Participants examined concrete examples of implementation in Senegal, which served as a case study for the sustainability of market-shaping initiatives. Simultaneously, the dialogue shifted to the frontlines of crisis, with a detailed report on the WHO’s emergency response activities in Gaza. This session highlighted the critical nature of the "One Health" approach, which recognizes the interconnectedness of human, animal, and environmental health in mitigating biological risks and zoonotic threats.
Day 3: Future-Proofing and Structural Integration
The final day was dedicated to the synthesis of findings and the alignment of future strategies. Discussions focused on the UHC-Partnership, specifically the achievements from 2021–2024 in Belgium’s partner countries, such as the Democratic Republic of Congo. The dialogue concluded with a commitment to a renewed Country Cooperation Strategy, ensuring that Belgian bilateral cooperation and WHO country office programs function in closer synchronization.
Supporting Data: Evidence-Based Cooperation
The effectiveness of the Belgium-WHO partnership is anchored in evidence-based programming. Throughout the dialogue, both parties reviewed data-driven outcomes across several key pillars:
Access to Medicines and Local Production
A cornerstone of the discussion was the sustainability of the Access to Medicines initiative. WHO experts presented data suggesting that market-shaping—the process of influencing the supply and demand for essential medicines—is essential to reduce costs and improve availability. The collaboration in Senegal has demonstrated that by fostering local production capacity, countries can reduce their reliance on fragile international supply chains.
Universal Health Coverage (UHC) Results
Reviewing the 2021–2024 cycle, the partners noted significant progress in the UHC-Partnership. By focusing on primary health care (PHC) and integrating mental health services into the PHC framework, the partnership has helped standardize care delivery in several partner nations. In the Democratic Republic of Congo, the synergy between Belgian bilateral support and WHO technical guidance has resulted in improved health infrastructure and increased immunization coverage, even in areas previously considered "hard-to-reach."
Neglected Tropical Diseases (NTDs) and Sexual/Reproductive Health
The partners also audited progress in specific programmatic areas, such as the fight against Neglected Tropical Diseases and the advancement of Sexual and Reproductive Health and Rights (SRHR). The review confirmed that funding directed toward these areas has yielded measurable public health dividends, provided that the interventions remain firmly grounded in clinical evidence and community-led feedback.
Official Responses: Strengthening the Multilateral Compact
The dialogue served as a platform for official expressions of mutual confidence.
Mr. Koen Van Acoleyen, Minister Counselor at the Permanent Representation of Belgium to the UN, highlighted the importance of transparency and collaborative navigation during these "challenging times." He remarked, "We are honoured that we can walk this road together," reflecting the sentiment that Belgium views the WHO not just as a recipient of funding, but as a strategic partner in the complex endeavor of global governance.
Dr. Catharina Boehme, Assistant Director-General for External Relations and Governing Bodies at the WHO, expressed deep appreciation for the unique structure of the Belgian delegation. "We thank you for your support, honesty, and strong engagement for global health," she stated. She specifically highlighted the operational success in Mozambique and Senegal as the "gold standard" for what can be achieved when donor resources are matched with WHO’s technical and logistical expertise.
Mr. Dirk Brems, Director of Thematic and Multilateral Cooperation at the Belgian Directorate-General for Development Cooperation and Humanitarian Aid, emphasized the emotional and professional pride taken in the partnership. "We recognize WHO as a trustworthy partner in global health. We felt proud hearing how crucial our support is to the Organization and how it is having a positive impact at country, regional, and global levels," he noted.
Implications: A Roadmap for the 14th General Programme of Work
The implications of this strategic dialogue extend well beyond the immediate renewal of funding. By aligning the Belgium-WHO collaboration with the WHO’s 14th General Programme of Work (GPW14), the two entities have signaled a shift toward a more integrated, long-term approach to health security.
1. The Primacy of UHC as a Foundation for Security
The dialogue reaffirmed that Universal Health Coverage is not just a social goal but a cornerstone of national and global security. By strengthening health systems at the primary level, countries are better prepared to detect and respond to the next pandemic. This shift from reactive, emergency-only funding to proactive, system-strengthening funding is a major outcome of the meeting.
2. Deepening Country-Level Alignment
Perhaps the most significant implication for future work is the move toward tighter integration between Belgium’s bilateral development cooperation and the WHO’s country offices. By eliminating the "silos" that often separate donor projects from local health ministry agendas, the partners hope to maximize the impact of every Euro spent.
3. Addressing Biological Risks
In an era of accelerated biological risks and zoonotic spillover, the dialogue solidified the commitment to the "One Health" framework. The inclusion of these topics in the high-level dialogue indicates that the Belgium-WHO relationship is evolving to address modern, non-traditional health threats that require cross-sectoral collaboration.
4. Sustaining Multilateralism
In an international climate where multilateral institutions are frequently under pressure, the Belgium-WHO strategic dialogue serves as a robust defense of the multilateral model. By explicitly committing to a "renewed Country Cooperation Strategy," both parties have affirmed their belief that global health challenges—whether they be the eradication of a tropical disease or the prevention of a global pathogen outbreak—cannot be solved by any one nation in isolation.
As the Belgian delegation returned from Geneva, the takeaway was clear: the partnership is moving into a new phase. It is one characterized by increased technical alignment, a focus on local sustainability, and an unwavering commitment to the idea that health is a fundamental right, requiring the collective effort of the international community. Through this strategic dialogue, Belgium and the WHO have set a standard for what a modernized, evidence-based, and deeply committed health partnership looks like in the 21st century.
About the Author
